Literature DB >> 1452246

Serum adenosine deaminase activity in bacillary or paucibacillary pulmonary tuberculosis.

V Lakshmi1, R R Rao, N Joshi, P N Rao.   

Abstract

Serum Adenosine Deaminase (ADA) enzyme levels were estimated in 61 patients with symptoms and signs suggestive of Pulmonary Tuberculosis and correlated with "Gold standards" such as smear positivity of sputum for Acid Fast bacilli, Tuberculin skin testing and Radiological evidence. The mean ADA levels in smear and Tuberculin negative patients was 13.13 +/- 5.97 u/L, while in those with smear and/or strongly positive Tuberculin reaction, the mean levels of ADA were 33.52 +/- 15.22 u/L. The mean serum ADA levels in 25 healthy voluntary donors with no evidence of active or old Tuberculous lesion, were found to be 16.5 +/- 3.18 u/L. The specificity, sensitivity, positive predictive value and negative predictive value of the test was found to be 87%, 71%, 90% and 66.5% respectively. The results conclude that the serum ADA value is sufficiently useful in identifying those patients in whom the diagnosis of Pulmonary Tuberculosis should be actively considered.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1452246

Source DB:  PubMed          Journal:  Indian J Pathol Microbiol        ISSN: 0377-4929            Impact factor:   0.740


  3 in total

1.  Effect of Lactobacillus supplementation on immune status of malnourished pre-school children.

Authors:  S Devi; P Yasoda Devi; M S Prakash
Journal:  Indian J Pediatr       Date:  1999 Sep-Oct       Impact factor: 1.967

2.  Assessment of adenosine deaminase levels in rheumatoid arthritis patients receiving anti-TNF-alpha therapy.

Authors:  Burak Erer; Gulsen Yilmaz; Fatma Meric Yilmaz; Seyfettin Koklu
Journal:  Rheumatol Int       Date:  2008-10-25       Impact factor: 2.631

3.  Diagnostic value of serum adenosine deaminase level in pulmonary tuberculosis.

Authors:  Shahla Afrasiabian; Behzad Mohsenpour; Katayoun Haji Bagheri; Naseh Sigari; Kaveh Aftabi
Journal:  J Res Med Sci       Date:  2013-03       Impact factor: 1.852

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.